Interleukin-23 Receptor and Interleukin-17 Receptor A: Splice Variants, Isoforms and Their Relationship With Periodontitis—A Systematic Review and Bioinformatic Analysis
Mario Alberto Alarcón-Sánchez, Celia Guerrero-Velázquez, Daniel Ortuño-Sahagún, Sarah Monserrat Lomelí-Martínez, Julieta Sarai Becerra-Ruiz, Javier Flores-Fraile, Artak Heboyan
{"title":"Interleukin-23 Receptor and Interleukin-17 Receptor A: Splice Variants, Isoforms and Their Relationship With Periodontitis—A Systematic Review and Bioinformatic Analysis","authors":"Mario Alberto Alarcón-Sánchez, Celia Guerrero-Velázquez, Daniel Ortuño-Sahagún, Sarah Monserrat Lomelí-Martínez, Julieta Sarai Becerra-Ruiz, Javier Flores-Fraile, Artak Heboyan","doi":"10.1111/jcmm.71325","DOIUrl":null,"url":null,"abstract":"<p>This systematic review aimed to: (1) identify the splicing variants of <i>IL23R</i> and <i>IL17RA</i> reported in the literature; (2) perform a multiple alignment analysis to describe the isoforms of IL-23R and IL-17RA; and (3) compare the expression levels of IL-23R, IL-17RA, and their soluble isoforms (sIL-23R and sIL-17RA) in patients with periodontitis and periodontally healthy individuals. The study protocol followed PRISMA guidelines and was registered in PROSPERO (CRD420251267367). Six databases (PubMed, ScienceDirect, Scopus, Web of Science, EBSCO, and Google Scholar) were searched without restrictions on year or language. The descriptors used were: ‘Interleukin-23 Receptor,’ ‘IL-23R,’ ‘Interleukin-17 Receptor A’ ‘IL-17RA,’ ‘Alternative Splicing,’ ‘Splice Variants,’ ‘Isoforms,’ and ‘Periodontitis.’ The bioinformatics analysis was performed using CLUSTALW (V.1.83), InterPro and DeepTMHMM. Risk of bias was assessed with the QUIN and JBI tools for cross-sectional studies. Of 104 articles, four in vitro studies and eight cross-sectional studies were included. Qualitative analysis revealed that to date there are 32 splicing variants of the <i>IL23R</i> gene, while only one splicing variant has been reported for <i>IL17RA</i>. CLUSTALW, InterPro and DeepTMHMM analysis showed that these splicing variants result in 23 isoforms which can be soluble forms, complete intracellular peptides, truncated extracellular or intracellular peptides, or complete structures with truncated extracellular and/or intracellular domains. All studies had a low risk of bias. IL-23R and IL-17RA exhibit structural diversity resulting from alternative splicing, with IL-23R demonstrating significantly greater isoform complexity. However, the biological significance of these isoforms in periodontitis remains unclear and requires further investigation.</p>","PeriodicalId":101321,"journal":{"name":"JOURNAL OF CELLULAR AND MOLECULAR MEDICINE","volume":"30 16","pages":""},"PeriodicalIF":4.7000,"publicationDate":"2026-08-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/jcmm.71325","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JOURNAL OF CELLULAR AND MOLECULAR MEDICINE","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/jcmm.71325","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
This systematic review aimed to: (1) identify the splicing variants of IL23R and IL17RA reported in the literature; (2) perform a multiple alignment analysis to describe the isoforms of IL-23R and IL-17RA; and (3) compare the expression levels of IL-23R, IL-17RA, and their soluble isoforms (sIL-23R and sIL-17RA) in patients with periodontitis and periodontally healthy individuals. The study protocol followed PRISMA guidelines and was registered in PROSPERO (CRD420251267367). Six databases (PubMed, ScienceDirect, Scopus, Web of Science, EBSCO, and Google Scholar) were searched without restrictions on year or language. The descriptors used were: ‘Interleukin-23 Receptor,’ ‘IL-23R,’ ‘Interleukin-17 Receptor A’ ‘IL-17RA,’ ‘Alternative Splicing,’ ‘Splice Variants,’ ‘Isoforms,’ and ‘Periodontitis.’ The bioinformatics analysis was performed using CLUSTALW (V.1.83), InterPro and DeepTMHMM. Risk of bias was assessed with the QUIN and JBI tools for cross-sectional studies. Of 104 articles, four in vitro studies and eight cross-sectional studies were included. Qualitative analysis revealed that to date there are 32 splicing variants of the IL23R gene, while only one splicing variant has been reported for IL17RA. CLUSTALW, InterPro and DeepTMHMM analysis showed that these splicing variants result in 23 isoforms which can be soluble forms, complete intracellular peptides, truncated extracellular or intracellular peptides, or complete structures with truncated extracellular and/or intracellular domains. All studies had a low risk of bias. IL-23R and IL-17RA exhibit structural diversity resulting from alternative splicing, with IL-23R demonstrating significantly greater isoform complexity. However, the biological significance of these isoforms in periodontitis remains unclear and requires further investigation.
本系统综述旨在:(1)鉴定文献中报道的IL23R和IL17RA的剪接变体;(2)进行多重比对分析,以描述IL-23R和IL-17RA的同工型;(3)比较牙周炎患者和牙周健康人群中IL-23R、IL-17RA及其可溶性异构体sIL-23R和sIL-17RA的表达水平。研究方案遵循PRISMA指南,并在PROSPERO注册(CRD420251267367)。6个数据库(PubMed、ScienceDirect、Scopus、Web of Science、EBSCO和b谷歌Scholar)在没有年份和语言限制的情况下进行了检索。使用的描述符是:“白介素-23受体”、“IL-23R”、“白介素-17受体A”、“IL-17RA”、“选择性剪接”、“剪接变体”、“异构体”和“牙周炎”。使用CLUSTALW (V.1.83)、InterPro和DeepTMHMM进行生物信息学分析。采用横断面研究的QUIN和JBI工具评估偏倚风险。在104篇文章中,包括4项体外研究和8项横断面研究。定性分析显示,迄今为止,IL23R基因有32个剪接变体,而IL17RA只有一个剪接变体被报道。CLUSTALW、InterPro和DeepTMHMM分析表明,这些剪接变异产生23种同工异构体,它们可以是可溶性形式、完整的细胞内肽、截断的细胞外或细胞内肽,或具有截断的细胞外和/或细胞内结构域的完整结构。所有研究的偏倚风险都很低。IL-23R和IL-17RA由于选择性剪接而表现出结构多样性,其中IL-23R表现出更大的同工异构体复杂性。然而,这些异构体在牙周炎中的生物学意义尚不清楚,需要进一步研究。
期刊介绍:
The Journal of Cellular and Molecular Medicine serves as a bridge between physiology and cellular medicine, as well as molecular biology and molecular therapeutics. With a 20-year history, the journal adopts an interdisciplinary approach to showcase innovative discoveries.
It publishes research aimed at advancing the collective understanding of the cellular and molecular mechanisms underlying diseases. The journal emphasizes translational studies that translate this knowledge into therapeutic strategies. Being fully open access, the journal is accessible to all readers.